These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18682662)

  • 1. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.
    Zhu ZB; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Shen WF
    Cardiology; 2009; 112(3):191-9. PubMed ID: 18682662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF
    Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
    Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
    Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
    Ferreira-González I; Marsal JR; Ribera A; Permanyer-Miralda G; García-Del Blanco B; Martí G; Cascant P; Martín-Yuste V; Brugaletta S; Sabaté M; Alfonso F; Capote ML; De La Torre JM; Ruíz-Lera M; Sanmiguel D; Cárdenas M; Pujol B; Baz JA; Iñiguez A; Trillo R; González-Béjar O; Casanova J; Sánchez-Gila J; García-Dorado D
    Circulation; 2010 Sep; 122(10):1017-25. PubMed ID: 20733100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients.
    Ruchin PE; Trabattoni D; Fabbiocchi F; Montorsi P; Lualdi A; Ravagnani P; Grancini L; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Int J Cardiol; 2009 May; 134(2):231-7. PubMed ID: 18582971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.
    Zhang RY; Ni JW; Zhang JS; Hu J; Yang ZK; Zhang Q; Lü AK; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1176-81. PubMed ID: 16863609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents.
    Sukhija R; Aronow WS; Palaniswamy C; Singh T; Sukhija R; Kalapatapu K; Mohan D; Pucillo AL; Sorbera C; Kakar P; Weiss MB; Lal P; Monsen CE
    Am J Cardiol; 2010 Feb; 105(3):293-6. PubMed ID: 20102937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
    Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
    Wenaweser P; Daemen J; Zwahlen M; van Domburg R; Jüni P; Vaina S; Hellige G; Tsuchida K; Morger C; Boersma E; Kukreja N; Meier B; Serruys PW; Windecker S
    J Am Coll Cardiol; 2008 Sep; 52(14):1134-40. PubMed ID: 18804739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.